drugset / Trial / NCT01602198

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

NCT01602198 ↗

Terminated 1 enrolled The Cleveland Clinic
RandomizedParallel-groupDouble-blind

Summary

The goal of this project is to determine if task-activated fMRI is sensitive to the central cholinergic deficit associated with Mild Cognitive Impairment.

Timeline

Start
2011-06
Primary completion
2013-01
Completion
2013-01

Outcome

Outcome not reported

Stopped: “Study revised to use a different study medication and patient population.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rivastigmine Small molecule — Other